Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Expression profiling of archival renal tumors by quantitative PCR to validate prognostic markers.

Glenn ST, Jones CA, Liang P, Kaushik D, Gross KW, Kim HL.

Biotechniques. 2007 Nov;43(5):639-40, 642-3, 647.

PMID:
18072593
2.

Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.

Sánchez-Navarro I, Gámez-Pozo A, González-Barón M, Pinto-Marín A, Hardisson D, López R, Madero R, Cejas P, Mendiola M, Espinosa E, Vara JA.

Biotechniques. 2010 May;48(5):389-97. doi: 10.2144/000113388.

3.

MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens.

Weng L, Wu X, Gao H, Mu B, Li X, Wang JH, Guo C, Jin JM, Chen Z, Covarrubias M, Yuan YC, Weiss LM, Wu H.

J Pathol. 2010 Sep;222(1):41-51. doi: 10.1002/path.2736.

PMID:
20593407
4.

Validation of putative reference genes for normalization of Q-RT-PCR data from paraffin-embedded lymphoid tissue.

Green TM, de Stricker K, Møller MB.

Diagn Mol Pathol. 2009 Dec;18(4):243-9. doi: 10.1097/PDM.0b013e3181a06f42.

PMID:
19861891
5.

Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma.

Roberts RA, Sabalos CM, LeBlanc ML, Martel RR, Frutiger YM, Unger JM, Botros IW, Rounseville MP, Seligmann BE, Miller TP, Grogan TM, Rimsza LM.

Lab Invest. 2007 Oct;87(10):979-97. Epub 2007 Aug 13.

6.

Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.

Loudig O, Brandwein-Gensler M, Kim RS, Lin J, Isayeva T, Liu C, Segall JE, Kenny PA, Prystowsky MB.

Hum Pathol. 2011 Dec;42(12):1911-22. doi: 10.1016/j.humpath.2011.02.011. Epub 2011 Jun 17.

PMID:
21683979
7.

Identification of endogenous reference genes for qRT-PCR analysis in normal matched breast tumor tissues.

Gur-Dedeoglu B, Konu O, Bozkurt B, Ergul G, Seckin S, Yulug IG.

Oncol Res. 2009;17(8):353-65.

PMID:
19544972
8.

A reliable method for the selection of exploitable melanoma archival paraffin embedded tissues for transcript biomarker profiling.

Lebbe C, Guedj M, Basset-Seguin N, Podgorniak MP, Menashi S, Janin A, Mourah S.

PLoS One. 2012;7(1):e29143. doi: 10.1371/journal.pone.0029143. Epub 2012 Jan 17.

9.

Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization.

Haller F, Kulle B, Schwager S, Gunawan B, von Heydebreck A, Sültmann H, Füzesi L.

Anal Biochem. 2004 Dec 1;335(1):1-9.

PMID:
15519565
10.

Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues.

Lyons-Weiler M, Hagenkord J, Sciulli C, Dhir R, Monzon FA.

Diagn Mol Pathol. 2008 Mar;17(1):3-13. doi: 10.1097/PDM.0b013e31815aca30.

PMID:
18303412
11.

Reference genes for gene expression analysis by real-time reverse transcription polymerase chain reaction of renal cell carcinoma.

Bjerregaard H, Pedersen S, Kristensen SR, Marcussen N.

Diagn Mol Pathol. 2011 Dec;20(4):212-7. doi: 10.1097/PDM.0b013e318212e0a9.

PMID:
22089348
12.

Targeted gene-expression analysis by genome-controlled reverse transcription-PCR.

Stenman J, Paju A, Rissanen O, Tenkanen T, Haglund C, Räsänen J, Salo J, Stenman UH, Orpana A.

Clin Chem. 2006 Nov;52(11):1988-96. Epub 2006 Sep 21.

13.

Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.

Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, Kristiansen G, Paradiso A, Hartmann O, Margossian A, Martens J, Schwope I, Lukas A, Müller V, Milde-Langosch K, Nährig J, Foekens J, Maier S, Schmitt M, Lesche R.

J Clin Oncol. 2008 Nov 1;26(31):5036-42. doi: 10.1200/JCO.2007.14.1697. Epub 2008 Aug 18.

PMID:
18711169
14.
15.

Selection of REFERENCE genes for normalization of qRT-PCR data derived from FFPE breast tumors.

Drury S, Anderson H, Dowsett M.

Diagn Mol Pathol. 2009 Jun;18(2):103-7. doi: 10.1097/PDM.0b013e31817c1ae2.

PMID:
19430294
16.

Optimized protocol for gene expression analysis in formalin-fixed, paraffin-embedded tissue using real-time quantitative polymerase chain reaction.

Votavova H, Forsterova K, Stritesky J, Velenska Z, Trneny M.

Diagn Mol Pathol. 2009 Sep;18(3):176-82. doi: 10.1097/PDM.0b013e31818d1091.

PMID:
19704263
17.

Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.

Sadi AM, Wang DY, Youngson BJ, Miller N, Boerner S, Done SJ, Leong WL.

BMC Cancer. 2011 Jun 16;11:253:1-13. doi: 10.1186/1471-2407-11-25.

18.

Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology.

Hasemeier B, Christgen M, Kreipe H, Lehmann U.

BMC Biotechnol. 2008 Nov 27;8:90. doi: 10.1186/1472-6750-8-90.

19.

Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues.

Koch I, Slotta-Huspenina J, Hollweck R, Anastasov N, Hofler H, Quintanilla-Martinez L, Fend F.

Diagn Mol Pathol. 2006 Sep;15(3):149-56.

PMID:
16932070
20.

RNA expression analysis of formalin-fixed paraffin-embedded tumors.

Penland SK, Keku TO, Torrice C, He X, Krishnamurthy J, Hoadley KA, Woosley JT, Thomas NE, Perou CM, Sandler RS, Sharpless NE.

Lab Invest. 2007 Apr;87(4):383-91. Epub 2007 Feb 12.

Supplemental Content

Support Center